Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Funpep Co., Ltd. (4881:JPX), powered by AI.
Funpep Co., Ltd. is currently trading at ¥62. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Funpep Co., Ltd. on Alpha Lenz.
View Funpep Co., Ltd.'s valuation metrics on Alpha Lenz.
“Funpep Co., Ltd.'s ROE is -95.3%. Explore profitability and growth together.”
Ask for details →Funpep Co., Ltd. is a biotechnology company engaged in pioneering research and development of innovative therapeutic solutions. This company focuses primarily on the discovery and development of novel treatments for various diseases using cutting-edge peptide technology. Based on advanced research, Funpep Co., Ltd. targets unmet medical needs in sectors such as oncology, autoimmune disorders, and inflammatory conditions. By collaborating with top-tier research institutions and leveraging state-of-the-art laboratories, Funpep Co., Ltd. aims to bring breakthrough therapies to market. Operating in the biotechnology sector, it plays a crucial role in advancing medical science, offering potential treatment options that could significantly improve patient outcomes while contributing to the broader healthcare and pharmaceutical industries.
“Funpep Co., Ltd.'s ROE is -95.3%. Explore profitability and growth together.”
Ask for details →Funpep Co., Ltd. (ticker: 4881) is a company listed on JPX in the Healthcare sector (Biotechnology). It has approximately 15 employees.
The current price is 62 with a P/E ratio of -x and P/B of -x.
ROE is -95.30% and operating margin is -525053.50%. Annual revenue is $314,000.